欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0737/002
药品名称Pemetrexed Seacross
活性成分
    • pemetrexed disodium 500.0 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Seacross Pharmaceuticals Limited
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Malta (MT)
    • Cyprus (CY)
      Pemetrexed Seacross 500 mg powder for concentrate for solution for infusion
    • Germany (DE)
      Pemetrexed Seacross 500 mg Pulver für ein Konzentrat zur Herst. einer Infusionslösung
    • Bulgaria (BG)
      Pemetrexed Seacross
    • Romania (RO)
      Pemetrexed Novamed 500 mg pulbere pentru concentrat pentru soluţie perfuzabilă
许可日期2019/01/09
最近更新日期2023/04/25
药物ATC编码
    • L01BA04 pemetrexed
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase